| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. is a 10% Owner at CDXS with holdings across 9 companies. Recent SEC Form 4 filings include 25 buys and 14 sells.
Estimated insider holdings value: $139.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2021 | HROW Harrow, Inc. | 10% Owner | Buy | 72,500 | $8.62 | $624,697.15 | +1.1% | +24.3% | -2.4% | |
| Aug 6, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 604,500 | $5.83 | $3,523,187.20 | -5.6% | +9.4% | -49.9% | |
| Jul 21, 2021 | HROW Harrow, Inc. | - | Buy | 20,000 | $7.31 | $146,289.84 | +0.2% | +33.2% | -4.6% | |
| Jun 18, 2021 | HROW Harrow, Inc. | - | Buy | 74,584 | $8.34 | $622,389.01 | +1.2% | +10.3% | -21.4% | |
| Jun 15, 2021 | ETON Eton Pharmaceuticals, Inc. | - | Sell | 105,000 | $8.07 | $847,350.00 | -2.8% | -25.8% | -57.0% | |
| May 27, 2021 | ETON Eton Pharmaceuticals, Inc. | - | Sell | 242,300 | $8.52 | $2,064,511.00 | -2.0% | -40.5% | -62.7% | |
| Dec 22, 2020 | HROW Harrow, Inc. | - | Buy | 106,416 | $5.26 | $559,482.03 | +1.2% | - | - | |
| Oct 16, 2020 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Buy | 400,000 | $7.00 | $2,800,000.00 | +11.0% | - | - | |
| Sep 30, 2020 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 50,000 | $16.00 | $800,000.00 | +2.1% | - | - | |
| Sep 24, 2020 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 300,000 | $16.87 | $5,061,000.00 | +13.6% | - | - |